Cargando…
Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments
MOTIVATION: The efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC(50), can be derived. The Marquardt–Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are how...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612849/ https://www.ncbi.nlm.nih.gov/pubmed/31510684 http://dx.doi.org/10.1093/bioinformatics/btz335 |
_version_ | 1783432951077273600 |
---|---|
author | Labelle, Caroline Marinier, Anne Lemieux, Sébastien |
author_facet | Labelle, Caroline Marinier, Anne Lemieux, Sébastien |
author_sort | Labelle, Caroline |
collection | PubMed |
description | MOTIVATION: The efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC(50), can be derived. The Marquardt–Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are however limited and can lead to biased conclusions. The approach does not evaluate the certainty (or uncertainty) of the estimates nor does it allow for the statistical comparison of two datasets. To compensate for these shortcomings, intuition plays an important role in the interpretation of results and the formulations of conclusions. We here propose a Bayesian inference methodology for the analysis and comparison of dose–response experiments. RESULTS: Our results well demonstrate the informativeness gain of our Bayesian approach in comparison to the commonly used Marquardt–Levenberg algorithm. It is capable to characterize the noise of dataset while inferring probable values distributions for the efficacy metrics. It can also evaluate the difference between the metrics of two datasets and compute the probability that one value is greater than the other. The conclusions that can be drawn from such analyzes are more precise. AVAILABILITY AND IMPLEMENTATION: We implemented a simple web interface that allows the users to analyze a single dose–response dataset, as well as to statistically compare the metrics of two datasets. |
format | Online Article Text |
id | pubmed-6612849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-66128492019-07-12 Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments Labelle, Caroline Marinier, Anne Lemieux, Sébastien Bioinformatics Ismb/Eccb 2019 Conference Proceedings MOTIVATION: The efficacy of a chemical compound is often tested through dose–response experiments from which efficacy metrics, such as the IC(50), can be derived. The Marquardt–Levenberg algorithm (non-linear regression) is commonly used to compute estimations for these metrics. The analysis are however limited and can lead to biased conclusions. The approach does not evaluate the certainty (or uncertainty) of the estimates nor does it allow for the statistical comparison of two datasets. To compensate for these shortcomings, intuition plays an important role in the interpretation of results and the formulations of conclusions. We here propose a Bayesian inference methodology for the analysis and comparison of dose–response experiments. RESULTS: Our results well demonstrate the informativeness gain of our Bayesian approach in comparison to the commonly used Marquardt–Levenberg algorithm. It is capable to characterize the noise of dataset while inferring probable values distributions for the efficacy metrics. It can also evaluate the difference between the metrics of two datasets and compute the probability that one value is greater than the other. The conclusions that can be drawn from such analyzes are more precise. AVAILABILITY AND IMPLEMENTATION: We implemented a simple web interface that allows the users to analyze a single dose–response dataset, as well as to statistically compare the metrics of two datasets. Oxford University Press 2019-07 2019-07-05 /pmc/articles/PMC6612849/ /pubmed/31510684 http://dx.doi.org/10.1093/bioinformatics/btz335 Text en © The Author(s) 2019. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Ismb/Eccb 2019 Conference Proceedings Labelle, Caroline Marinier, Anne Lemieux, Sébastien Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title_full | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title_fullStr | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title_full_unstemmed | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title_short | Enhancing the drug discovery process: Bayesian inference for the analysis and comparison of dose–response experiments |
title_sort | enhancing the drug discovery process: bayesian inference for the analysis and comparison of dose–response experiments |
topic | Ismb/Eccb 2019 Conference Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612849/ https://www.ncbi.nlm.nih.gov/pubmed/31510684 http://dx.doi.org/10.1093/bioinformatics/btz335 |
work_keys_str_mv | AT labellecaroline enhancingthedrugdiscoveryprocessbayesianinferencefortheanalysisandcomparisonofdoseresponseexperiments AT marinieranne enhancingthedrugdiscoveryprocessbayesianinferencefortheanalysisandcomparisonofdoseresponseexperiments AT lemieuxsebastien enhancingthedrugdiscoveryprocessbayesianinferencefortheanalysisandcomparisonofdoseresponseexperiments |